Relationships between structure and vascular activity in a series of benzylisoquinolines.

Departamento de Farmacologia, Facultad de Farmacia, Universidad de Valencia, Spain.
British Journal of Pharmacology (Impact Factor: 4.99). 11/1997; 122(3):409-16. DOI: 10.1038/sj.bjp.0701410
Source: PubMed

ABSTRACT 1. In the present work, the properties of 3-methyl isoquinoline, 3,4-dihydropapaverine, tetrahydropapaverine and tetrahydropapaveroline were compared with those of papaverine and laudanosine. The work includes functional studies on rat isolated aorta contracted with noradrenaline, caffeine or KCl, and a determination of the affinity of the compounds for alpha1-adrenoceptors and calcium channel binding sites, with [3H]-prazosin, [3H]-nitrendipine and [3H]-(+)-cis-diltiazem binding to rat cerebral cortical membranes. The effects of papaverine derivatives on the different molecular forms of cyclic nucleotide phosphodiesterases (PDE) isolated from bovine aorta were also determined. 2. The three papaverine derivatives show greater affinity than papaverine for the [3H]-prazosin binding site. They are therefore more selective as inhibitors of [3H]-prazosin binding as opposed to [3H]-(+)-cis-diltiazem, while papaverine appears to have approximately equal affinity for both. [3H]-nitrendipine binding was not affected by either papaverine or papaverine derivatives in concentrations up to 100 microM. 3-Methylisoquinoline had no effect on any of the binding sites assayed. 3. Contractions evoked by noradrenaline (1 microM) in rat aorta were inhibited in a concentration-dependent manner by 3,4-dihydropapaverine, tetrahydropapaverine and with a lower potency, by tetrahydropapaveroline. In Ca2+-free solution, tetrahydropapaverine and to a lesser extent, tetrahydropapaveroline, inhibited the noradrenaline (1 microM) evoked contraction in a concentration-dependent manner and did not modify the phasic contractile response evoked by caffeine (10 mM). This suggests that these alkaloids do not act at the intracellular level, unlike papaverine which inhibits the contractile response to caffeine and noradrenaline. 4. Inositol phosphates formation induced by noradrenaline (1 microM) in rat aorta was inhibited by tetrahydropapaverine (100 microM) and tetrahydropapaveroline (300 microM), thus suggesting that alpha1D-adrenoceptors are coupled to phosphoinositide metabolism in rat aorta. 5. Unlike papaverine, which has a significant effect on all the PDE isoforms, the three alkaloids assayed did not have an inhibitory effect on the different forms of PDE isolated from bovine aorta. 6. These results provide evidence that papaverine derivatives with a partially or totally reduced isoquinoline ring have a greater affinity for alpha1-adrenoceptors and a lower affinity for benzothiazepine sites in the Ca2+-channel than papaverine. This structural feature also implies a loss of the inhibitory activity on PDE isoforms. The planarity of the isoquinoline ring (papaverine) impairs the interaction with the alpha1-adrenoceptor site and facilitates it with the Ca2+-channels and PDEs, whereas the more flexible tetrahydroisoquinoline ring increases the binding to alpha1-adrenoceptors.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The purpose of the present investigation was to clarify whether the hypotensive action of the protoberberine alkaloid, and dopamine receptor antagonist, (−)-stepholidine, can be ascribed to an effect on peripheral small arteries. For this purpose isolated mesenteric small arteries were suspended in microvascular myographs for isometric tension recording. Relaxations mediated by dopamine D1 receptors were antagonized by (−)-stepholidine. (−)-Stepholidine inhibited in a concentration-dependent manner the contractile responses evoked by noradrenaline (10−6 M), but not the contractile responses evoked by depolarizing solution (KCl, 60 mM) or 9,11-dideoxy-11α,9α-epoxymethano prostaglandin F2α (U46619, 10−7 M). Mechanical endothelial cell removal, blockade of K+ channels, muscarinic receptors or adrenoceptors did not influence the inhibitory effect of (−)-stepholidine on the contractile response evoked with noradrenaline in the segments.(−)-Stepholidine caused rightward shifts of the concentration–response curves for noradrenaline and phenylephrine. The pA2 values for (−)-stepholidine were 6.05 and 5.94 against noradrenaline and phenylephrine, respectively. Electrical field stimulation induced prazosin-sensitive frequency-dependent contractions in mesenteric small arteries. These contractions were significantly inhibited by 10−6 and 10−5 M (−)-stepholidine. In membranes from the rat cerebral cortex labelled with prazosin, (−)-stepholidine (10−7–10−4 M) completely inhibited the specific binding of the ligand with a pKi of 5.6. The present investigation suggests the inhibitory effect of (−)-stepholidine on the α1-adrenoceptor-mediated contractions induced by exogenously added and nerve-released noradrenaline in peripheral small arteries might contribute to a hypotensive effect of the drug.
    European Journal of Pharmacology 02/1999; · 2.68 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Effectiveness of topical Cilostazol-Phosphodiesterase III Inhibitor. Application for the treatment of arterial vasospasm SUMMARY Arterial spasm represents a common problem in microvascular surgery. Appropriate treatment of the triggering causes and topical application of spasmolytic agents could resolve the vessel constriction. Nonetheless, sometimes se-vere spasm develops leading to the failure of the reconstructive procedure. This study was conducted to reproduce the clinical setting of arterial spasm and investigate the potential therapeutic effect of the local application of Cilostazol, a selective phosphodiesterase III inhibitor, in DMSO vehicle, compared to the most widely used papaverine. The femoral artery of 30 male Wistar rats was interrupted and a microsurgical repair was performed (10/0 prolene). Norepinephrine solution (1.6 mg/ml) was applied topically to induce vasospasm. The animals were then divided in 5 groups and the vessels were treated respectively with saline solution (5), DMSO (5), papaverine 4 µM (5), pa-paverine 40 µM (5) and Cilostazol in DMSO solution 4 µM (10). Blood flow (l/min) was registered by an ultra-sonic doppler flowmeter (8 MHz). Statistically significant spasm resolving effect was shown in papaverine 40 µM (p<0.05) and Cilostazol group (p<0.001). Application of Cilostazol provoked greater increase in blood flow com-pared to papaverine at the same molar concentration. The results of this study indicates that Cilostazol in DMSO solution could be used as an effective topical vasodilating agent to resolve vasospasm in reconstructive surgery. delle Fosfodiesterasi III, in soluzione di DMSO (Dimetilsulfossido), comparandone l'ef-ficacia a quella dell'agente spasmolitico maggiormente utilizzato, la Papaverina. L'arteria femorale di 30 ratti maschi Wistar veniva interrotta e sottoposta a sutura microchirurgica (10/0 prolene). Una soluzione di norepinefrina (1.6 mg/ml) è stata applicata localmente per indurre il vasospasmo. Gli animali sono stati successivamente divisi in 5 gruppi, trattati rispettivamente con soluzione fisiologica (5), DMSO (5), papaverina 4 µM (5), papaverina 40 µM (5) e Cilo-stazolo in soluzione di DMSO 4 µM (10). Il flusso sanguigno (l/min) veniva registrato da una sonda Doppler (8 Corrispondence: Dr. Alex Pontini -Clinica di Chirurgia Plastica -Via Fosso Cavallaro 5 -36014, Santorso (Vi) -Tel. 049.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Bacopa monnieri (Brahmi) provides traditional cognitive treatments possibly reflecting improved cerebral hemodynamics. Little is known about the cardiovascular actions of Brahmi. We sought to assess its effects on blood pressure and on isolated arteries, thus providing insights to clinical applications. Intravenous Brahmi (20-60 mg/kg) was tested on arterial blood pressure and heart rate of anaesthetized rats. In vitro vasorelaxation was assessed in arteries, with and without blockers of nitric oxide synthase (L-NAME), cyclooxygenase (indomethacin), and mechanical de-endothelialisation. The effects of Brahmi on Ca(2+) influx and release from stores were investigated. Intravenous Brahmi extract (20-60 mg/kg) decreased systolic and diastolic pressures without affecting heart rate. Brahmi evoked relaxation in isolated arteries in order of potency: basilar (IC50=102 ± 16 μg/ml)>mesenteric (171 ± 31)>aortae (213 ± 68)>renal (IC50=375 ± 51)>tail artery (494 ± 93)>femoral arteries (>1,000 μg/ml). Two saponins, bacoside A3 and bacopaside II, had similar vasodilator actions (IC50=8.3 ± 1.7 and 19.5 ± 6.3 μM). In aortae, without endothelium or in L-NAME (10-4M), Brahmi was less potent (IC50=213 ± 68 to 2170 ± 664 and 1192 ± 167 μg/ml, respectively); indomethacin (10-5M) was ineffective. In tail artery, Brahmi inhibited K(+)-depolarization induced Ca(2+) influx and Ca(2+) release from the sarcoplasmic reticulum by phenylephrine (10-5M) or caffeine (20mM). Brahmi reduces blood pressure partly via releasing nitric oxide from the endothelium, with additional actions on vascular smooth muscle Ca(2+) homeostasis. Some Brahmi ingredients could be efficacious antihypertensives and the vasodilation could account for some medicinal actions.
    Journal of ethnopharmacology 09/2011; 137(1):790-5. · 2.32 Impact Factor

Full-text (2 Sources)

Available from
Jun 2, 2014